Keiran S M Smalley

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Histone Deacetylase

Basal Cell Carcinoma

Brain Metastases

Top Venues

The Journal of experimental medicine

Pigment cell & melanoma research

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Qianqian Ming, Daniel Antfolk, David A Price, Anna Manturova, Elliot Medina, Srishti Singh, Charlotte Mason, Timothy H Tran, Keiran S M Smalley, Daisy W Leung, Vincent C Luca
Structural basis for mouse LAG3 interactions with the MHC class II molecule I-A b . Nature communications 15 (1) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Manali S Phadke, Keiran S M Smalley
Targeting NRAS Mutations in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Zeynep Eroglu, Y Ann Chen, Inna Smalley, Jiannong Li, Joseph K Markowitz, Andrew S Brohl, Leticia Tetteh, Hayley Taylor, Vernon K Sondak, Nikhil I Khushalani, Keiran S M Smalley
Combined BRAF, MEK, and heat-shock protein 90 (HSP90) inhibition in advanced BRAF V600-mutant melanoma. Cancer (2023)
Manali S Phadke, Jiannong Li, Zhihua Chen, Paulo C Rodriguez, Jessica K Mandula, Lilit Karapetyan, Peter A Forsyth, Y Ann Chen, Keiran S M Smalley
Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models. Journal for immunotherapy of cancer 11 (12) (2023)
Michael F Emmons, Richard L Bennett, Alberto Riva, Kanchan Gupta, Larissa Anastasio Da Costa Carvalho, Chao Zhang, Robert J B Macaulay, Daphne Dupéré-Richér, Bin Fang, Edward Seto, John M Koomen, Jiannong Li, Yian Ann Chen, Peter A Forsyth, Jonathan D Licht, Keiran S M Smalley
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis. Nature communications 14 (1) (2023)
Inna Smalley, Adrienne Boire, Priscilla Brastianos, Harriet M Kluger, Eva Hernando-Monge, Peter A Forsyth, Kamran A Ahmed, Keiran S M Smalley, Sherise D Ferguson, Michael A Davies, Isabella C Glitza Oliva
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care. Pigment cell & melanoma research (2023)
Sathya Neelature Sriramareddy, Fernanda Faião-Flores, Michael F Emmons, Biswarup Saha, Srikumar P Chellappan, Clayton Wyatt, Inna Smalley, Jonathan D Licht, Michael A Durante, J William Harbour, Keiran S M Smalley
HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma. Cancer gene therapy (2022)
Keiran S M Smalley
Too much fuel on the fire? Linking obesity, metabolism and melanoma outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Inna Smalley, Keiran S M Smalley
Space Is the Place: Mapping the Cell-Cell Interactions That Predict Immunotherapy Responses in Melanoma. Cancer research 82 (18) (2022)
Alcida Karz, Maya Dimitrova, Kevin Kleffman, Christopher Alvarez-Breckenridge, Michael B Atkins, Adrienne Boire, Marcus Bosenberg, Priscilla Brastianos, Daniel P Cahill, Qing Chen, Sherise D Ferguson, Peter A Forsyth, Isabella C Glitza Oliva, Sarah B Goldberg, Sheri L Holmen, Jonathan P S Knisely, Glenn Merlino, Don X Nguyen, Michael E Pacold, Eva Perez-Guijarro, Keiran S M Smalley, Hussein A Tawbi, Patrick Y Wen, Michael A Davies, Harriet M Kluger, Janice M Mehnert, Eva Hernando-Monge
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment cell & melanoma research 35 (6) (2022)
Jiannong Li, Inna Smalley, Zhihua Chen, Jheng-Yu Wu, Manali S Phadke, Jamie K Teer, Thanh Nguyen, Florian A Karreth, John M Koomen, Amod A Sarnaik, Jonathan S Zager, Nikhil I Khushalani, Ahmad A Tarhini, Vernon K Sondak, Paulo C Rodriguez, Jane L Messina, Yian Ann Chen, Keiran S M Smalley
Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Manali Phadke, Alpaslan Ozgun, Zeynep Eroglu, Keiran S M Smalley
Melanoma brain metastases: Biological basis and novel therapeutic strategies. Experimental dermatology (2021)
Isabella C Glitza Oliva, Keiran S M Smalley, Priscilla K Brastianos, Michael A Davies, Ian McCutcheon, James K C Liu, Kamran A Ahmed, John A Arrington, Brittany R Evernden, Inna Smalley, Zeynep Eroglu, Nikhil Khushalani, Kim Margolin, Harriet Kluger, Michael B Atkins, Hussein Tawbi, Adrienne Boire, Peter A Forsyth
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions. Pigment cell & melanoma research 33 (4) (2020)
Jessica Gonçalves, Michael F Emmons, Fernanda Faião-Flores, Andrew E Aplin, J William Harbour, Jonathan D Licht, Márcia R Wink, Keiran S M Smalley
Decitabine limits escape from MEK inhibition in uveal melanoma. Pigment cell & melanoma research 33 (3) (2019)